Literature DB >> 20439428

Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development.

Pipsa Saharinen1, Hanna Helotera, Juho Miettinen, Camilla Norrmen, Gabriela D'Amico, Michael Jeltsch, Tobias Langenberg, Wouter Vandevelde, Annelii Ny, Mieke Dewerchin, Peter Carmeliet, Kari Alitalo.   

Abstract

The Claudin-like protein of 24 kDa (CLP24) is a hypoxia-regulated transmembrane protein of unknown function. We show here that clp24 knockdown in Danio rerio and Xenopus laevis results in defective lymphatic development. Targeted disruption of Clp24 in mice led to enlarged lymphatic vessels having an abnormal smooth muscle cell coating. We also show that the Clp24(-/-) phenotype was further aggravated in the Vegfr2(+/LacZ) or Vegfr3(+/LacZ) backgrounds and that CLP24 interacts with vascular endothelial growth factor receptor-2 (VEGFR-2) and VEGFR-3 and attenuates the transcription factor CREB phosphorylation via these receptors. Our results indicate that CLP24 is a novel regulator of VEGFR-2 and VEGFR-3 signaling pathways and of normal lymphatic vessel structure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20439428      PMCID: PMC2861186          DOI: 10.1101/gad.565010

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  25 in total

1.  PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature.

Authors:  Taija Mäkinen; Ralf H Adams; John Bailey; Qiang Lu; Andrew Ziemiecki; Kari Alitalo; Rüdiger Klein; George A Wilkinson
Journal:  Genes Dev       Date:  2005-02-01       Impact factor: 11.361

Review 2.  Lymphangiogenesis: Molecular mechanisms and future promise.

Authors:  Tuomas Tammela; Kari Alitalo
Journal:  Cell       Date:  2010-02-19       Impact factor: 41.582

3.  Maternally expressed PGK-Cre transgene as a tool for early and uniform activation of the Cre site-specific recombinase.

Authors:  Y Lallemand; V Luria; R Haffner-Krausz; P Lonai
Journal:  Transgenic Res       Date:  1998-03       Impact factor: 2.788

4.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.

Authors:  F Shalaby; J Rossant; T P Yamaguchi; M Gertsenstein; X F Wu; M L Breitman; A C Schuh
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

5.  Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis.

Authors:  Tatiana V Petrova; Terhi Karpanen; Camilla Norrmén; Russell Mellor; Tomoki Tamakoshi; David Finegold; Robert Ferrell; Dontscho Kerjaschki; Peter Mortimer; Seppo Ylä-Herttuala; Naoyuki Miura; Kari Alitalo
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

6.  Cardiovascular failure in mouse embryos deficient in VEGF receptor-3.

Authors:  D J Dumont; L Jussila; J Taipale; A Lymboussaki; T Mustonen; K Pajusola; M Breitman; K Alitalo
Journal:  Science       Date:  1998-10-30       Impact factor: 47.728

7.  A novel four transmembrane spanning protein, CLP24. A hypoxically regulated cell junction protein.

Authors:  Jonathan Kearsey; Silvere Petit; Catherine De Oliveira; Fabien Schweighoffer
Journal:  Eur J Biochem       Date:  2004-07

8.  Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.

Authors:  Marika J Karkkainen; Paula Haiko; Kirsi Sainio; Juha Partanen; Jussi Taipale; Tatiana V Petrova; Michael Jeltsch; David G Jackson; Marja Talikka; Heikki Rauvala; Christer Betsholtz; Kari Alitalo
Journal:  Nat Immunol       Date:  2003-11-23       Impact factor: 25.606

9.  Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice.

Authors:  E Gustafsson; C Brakebusch; K Hietanen; R Fässler
Journal:  J Cell Sci       Date:  2001-02       Impact factor: 5.285

10.  VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis.

Authors:  Satoshi Hirakawa; Shohta Kodama; Rainer Kunstfeld; Kentaro Kajiya; Lawrence F Brown; Michael Detmar
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

View more
  14 in total

Review 1.  The genus Xenopus as a multispecies model for evolutionary and comparative immunobiology of the 21st century.

Authors:  Jacques Robert; Nicholas Cohen
Journal:  Dev Comp Immunol       Date:  2011-01-28       Impact factor: 3.636

Review 2.  The lymphatic vasculature in disease.

Authors:  Kari Alitalo
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

3.  Mechanoinduction of lymph vessel expansion.

Authors:  Lara Planas-Paz; Boris Strilić; Axel Goedecke; Georg Breier; Reinhard Fässler; Eckhard Lammert
Journal:  EMBO J       Date:  2011-12-13       Impact factor: 11.598

Review 4.  Intestinal lymphatic vasculature: structure, mechanisms and functions.

Authors:  Jeremiah Bernier-Latmani; Tatiana V Petrova
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-06-28       Impact factor: 46.802

5.  Molecular regulation of lymphangiogenesis in development and tumor microenvironment.

Authors:  Taotao Li; Jianfeng Yang; Quansheng Zhou; Yulong He
Journal:  Cancer Microenviron       Date:  2012-08-04

6.  Chemokine signaling directs trunk lymphatic network formation along the preexisting blood vasculature.

Authors:  Young Ryun Cha; Misato Fujita; Matthew Butler; Sumio Isogai; Eva Kochhan; Arndt F Siekmann; Brant M Weinstein
Journal:  Dev Cell       Date:  2012-04-17       Impact factor: 12.270

7.  VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.

Authors:  Tuomas Tammela; Georgia Zarkada; Harri Nurmi; Lars Jakobsson; Krista Heinolainen; Denis Tvorogov; Wei Zheng; Claudio A Franco; Aino Murtomäki; Evelyn Aranda; Naoyuki Miura; Seppo Ylä-Herttuala; Marcus Fruttiger; Taija Mäkinen; Anne Eichmann; Jeffrey W Pollard; Holger Gerhardt; Kari Alitalo
Journal:  Nat Cell Biol       Date:  2011-09-11       Impact factor: 28.824

Review 8.  The physiological and pathological functions of VEGFR3 in cardiac and lymphatic development and related diseases.

Authors:  Richard M Monaghan; Donna J Page; Pia Ostergaard; Bernard D Keavney
Journal:  Cardiovasc Res       Date:  2021-07-07       Impact factor: 10.787

Review 9.  Lymphatic vascular morphogenesis in development, physiology, and disease.

Authors:  Stefan Schulte-Merker; Amélie Sabine; Tatiana V Petrova
Journal:  J Cell Biol       Date:  2011-05-16       Impact factor: 10.539

10.  Tumor lymphangiogenesis as a potential therapeutic target.

Authors:  Tam Duong; Peter Koopman; Mathias Francois
Journal:  J Oncol       Date:  2012-02-16       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.